Cushing's syndrome (Q56228192)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Cushing's syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

0 references

Lynnette K Nieman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Ashley B Grossman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

John Newell-Price

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Xavier Bertagna

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

9522

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1605-1617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Occult Cushing's syndrome in type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The molecular pathogenesis of corticotroph tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cyclin D and cyclin E expression in normal and adenomatous pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The Cushing syndrome: an update on diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Propranolol Therapy for Ectopic β-Adrenergic Receptors in Adrenal Cushing's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercorti

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Activating mutations of the stimulatory G protein in the McCune-Albright syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Final adult height and body mass index after cure of paediatric Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Growth abnormalities associated with adrenal disorders and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Persistent cognitive impairment following surgical treatment of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Long-term negative impact on quality of life in patients with successfully treated Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Quality of life in patients after long-term biochemical cure of Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Markers of vascular function in hypertension due to Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Hyperhomocysteinemia in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome during pregnancy: personal experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Glucocorticoid action and the clinical features of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Diagnosis and complications of Cushing's syndrome: a consensus statement.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The effects of anti-convulsant drugs on adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome: A review of diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Salivary cortisol for screening of Cushing's syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Differential diagnosis and imaging in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Diagnostic errors after inferior petrosal sinus sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Preliminary observations using endocrine markers of pituitary venous dilution during bilateral simultaneous inferior petrosal sinus catheterization in Cushing's syndrome: is combined CRF and TRH stimulation of value?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cavernous and inferior petrosal sinus sampling in the evaluation of ACTH-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Internal jugular vein sampling in adrenocorticotropic hormone-dependent Cushing's syndrome: a comparison with inferior petrosal sinus sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Jugular venous sampling: an alternative to petrosal sinus sampling for the diagnostic evaluation of adrenocorticotropic hormone-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Octreoscan in patients with bronchial carcinoid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Medical therapy of Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing syndrome due to ectopic adrenocorticotropic hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

PPAR-gamma receptor ligands: novel therapy for pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Dopamine receptor expression and function in corticotroph pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cabergoline plus lanreotide for ectopic Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Retinoic acid prevents experimental Cushing syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Absence of peritumoral Crooke's change is associated with recurrence in surgically treated Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Cushing's syndrome: adrenalectomy and long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Laparoscopic transperitoneal adrenalectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Bilateral adrenalectomy for Cushing's syndrome: a comparison between laparoscopy and open surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

One hundred laparoscopic adrenalectomies: a single surgeon's experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The Nelson's syndrome... revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Neurosurgical Treatment of Nelson’s Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

Radiosurgery for Cushing's disease after failed transsphenoidal surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2968699-6

7 January 2021

10.1016/S0140-6736(06)68699-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16698415%20AND%20SRC:MED&resulttype=core&format=json